<DOC>
	<DOCNO>NCT00688558</DOCNO>
	<brief_summary>The purpose study evaluate safety JTT-705 demonstrate efficacy JTT-705 compare placebo co-administered simvastatin 40 mg patient low HDL</brief_summary>
	<brief_title>Safety Efficacy Study JTT-705 Combination With Simvastatin 40 mg Patients With Low High-Density Lipoprotein ( HDL ) Levels</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Dalcetrapib</mesh_term>
	<criteria>Patients lipid value indicate : HDLC ≤ 1.0 mmol/L ( 40 mg/dL ) TG ≤4.5 mmol/L ( 400 mg/dL ) Patients CHD CHD risk equivalent Male females 18 70 year age ( female patient must postmenopausal , surgically sterile use acceptable form contraception ) Body Mass Index ≥ 35 kg/m2 Females pregnant breastfeeding , females child bear potential use effective method contraception Concomitant use medication identify protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>